Targeting PI3K family with small-molecule inhibitors in cancer therapy: current clinical status and future directions
Crossref DOI link: https://doi.org/10.1186/s12943-024-02072-1
Published Online: 2024-08-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Li, Hongyao
Wen, Xiang
Ren, Yueting
Fan, Zhichao
Zhang, Jin
He, Gu
Fu, Leilei
Text and Data Mining valid from 2024-08-10
Version of Record valid from 2024-08-10
Article History
Received: 15 June 2024
Accepted: 25 July 2024
First Online: 10 August 2024
Declarations
:
: Not applicable.
: The authors declare no competing interests.